Picture courtesy The News Minute
Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI).
Now, Hyderabad-based Bharat Biotech followed suit in urging the DCGI for the approval for its indigenously made COVID vaccine Covaxin, reported India Today.
Bharat Biotech is indigenously developing Covaxin in association with the Indian Council of Medical Research (ICMR).
The Phase 3 trials of the respective vaccine candidates of both SII and Bharat Biotech are currently being conducted in India.
Malkangiri: If things go as per plan, flight services between Odisha’s Malkangiri town and Visakhapatnam…
Bhubaneswar: Unidentified miscreants allegedly attacked a man and kidnapped his female friend in Maitri Vihar…
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
This website uses cookies.